The U.S. Food and Drug Administration has put Novavax's trial of an experimental COVID-flu vaccine combination on hold after ...

Sanofi (SNYNF, SNY) said that the U.S. Food and Drug Administration has updated the label for FLUBLOK (Influenza Vaccine) to include ...

The US Food and Drug Administration (FDA) has updated the US label for French pharma major Sanofi’s Flublok (Influenza ...

Novavax’s plans for growth outside of its COVID program have been thrown into chaos after the FDA put the biooharma's flu ...

Novavax said a participant enrolled in a mid stage study of the combination vaccine last month reported symptoms of motor ...

The hold, which was made in response to a serious adverse event report, could impact the company’s plans to start a Phase 3 ...

"Today, we're proud to announce an important update to our label for FLUBLOK, from one of Sanofi's largest flu vaccine safety studies ever done in pregnant individuals, an important at-risk ...

Sanofi launches high-dose egg-based quadrivalent influenza vaccine (QIV-HD) in the UK ·       Developed with a higher antigen content to increase protection in older adults, a population at greater ...

NVAX's COVID-19-flu combination and stand-alone flu vaccines have been placed on hold after a study participant who took the ...

France considers blocking Sanofi's $16 billion consumer division sale to U.S. firm CD&R, citing concerns over healthcare ...

This summary highlights global health-related news, including the WHO's approval of a vaccine for adolescents, France seeking ...

Recent health news highlights include WHO's approval of an mpox vaccine for adolescents, $1 billion in WHO budget pledges, ...